is the amount of BR96 sFv-PE40 required to inhibit 50%

is the amount of BR96 sFv-PE40 required to inhibit 50% br96 The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic br96 lottery result Immunoconjugates were prepared between chimeric monoclonal antibody BR96 and the anticancer drug doxorubicin The monoclonal antibody binds an

br96 lottery result Assessment of trypsinlike immunoreactivity was useful in monitoring changes in pancreatic function The immunogenicity of BR96 sFv-PE40 could be inhibited by

br96 BR96 has been determined at Å resolution The structure has been compared with Lewis Y antigen-complexed structures of BR96 which were determined previously Touch Twin Marker BR96 Layout Marker